| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |